Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes

  • First published: 19 May 2026
  • Last modified: 19 May 2026
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-h6vhtk-05d3d5
Published by:
NHS England
Authority ID:
AA20005
Publication date:
19 May 2026
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

This is a notice of intention to make an award. NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU),on behalf of NHS England Specialised Commissioning (referred to as the Authority) invited suitably qualified and experienced providers to express interest in the provision of Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes by responding to this accreditation process.<br/><br/>Services are being commissioned across seven (7) geographical regions to serve the population of England, as outlined below:<br/><br/>Lot 1: London<br/>Lot 2: East of England<br/>Lot 3: South East<br/>Lot 4: South West<br/>Lot 5: Midlands<br/>Lot 6: North East and Yorkshire<br/>Lot 7: North West<br/><br/>- There is no restriction on the number of sites that may be commissioned.<br/>- Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.<br/><br/>Link to NHS England Regions:<br/>NHS England » Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).<br/><br/>Inherited cancer predisposition syndromes are genetic conditions that increase the risk of developing one or more types of cancer. Scanning will be commissioned for three rare inherited cancer predisposition syndromes; Li-Fraumeni syndrome (LFS), constitutional mismatch repair deficiency syndrome (CMMRD) and rhabdoid tumour predisposition syndrome (RTPS).<br/><br/>Published clinical guidelines for these conditions recommend the use of regular whole-body MRI (WBMRI) with the aim of detecting cancers at an early stage. The provision of expanded capacity for WBMRI scanning aims to improve clinical care of individuals once an inherited cancer predisposition has been diagnosed.<br/><br/>Providers will:<br/>• Provide, interpret and report WB-MRI Scanning for the patient cohort described.<br/>• Provide, interpret, and report brain MRI Scanning (the first one with contrast when possible).<br/>• Establish effective pathways (including sharing results) with providers.<br/>• Be linked to regional genetic centres to allow continuity of care.<br/>• Facilitate communication with referrers including consultant clinical geneticists<br/>• Have capacity to plan and undertake WBMRI under general anaesthetic if re-quired.<br/>• Have information governance processes that permit sharing clinical and imaging data across organisations involved with providing a cancer surveillance service, and collection of clinical outcome and monitoring data.<br/>• Engage positively with associated patient support groups.<br/>• Ensure clear communication with Genetics Services and patients, to support patients to make decisions on where to access screening.<br/>• Work collaboratively with other organisations e.g. within imaging networks, to provide scanning and reporting capacity and expertise to meet the needs of their population including transition between paediatric and adult services.<br/>• Operate Quality Assessment processes according to CQC standards<br/>• Screening will be in addition to breast screening undertaken through the National VHRS Programme<br/>• Provide facilities will be in line with NHS guidance on Facilities for diagnostic imaging and interventional radiology.<br/>• Support continued educational initiatives for non-genetics healthcare professionals to improve expertise and understanding of cancer predisposition syndromes.<br/>• Liaise with partners across cancer alliances to support early diagnosis innovation opportunities<br/>• Ensure screening frequency will be in accordance with surveillance protocols.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

NHS England

Wellington House, 133-135 Waterloo Rd

London

SE1 8UG

UK

Contact person: Jessica Gaucher-Thompson

E-mail: j.gaucher-thompson@nhs.net

NUTS: UKI

Internet address(es)

Main address: https://www.england.nhs.uk/

Address of the buyer profile: https://www.england.nhs.uk/

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes

II.1.2) Main CPV code

85100000

 

II.1.3) Type of contract

Services

II.1.4) Short description

This is a notice of intention to make an award. NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU),on behalf of NHS England Specialised Commissioning (referred to as the Authority) invited suitably qualified and experienced providers to express interest in the provision of Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes by responding to this accreditation process.<br/><br/>Services are being commissioned across seven (7) geographical regions to serve the population of England, as outlined below:<br/><br/>Lot 1: London<br/>Lot 2: East of England<br/>Lot 3: South East<br/>Lot 4: South West<br/>Lot 5: Midlands<br/>Lot 6: North East and Yorkshire<br/>Lot 7: North West<br/><br/>- There is no restriction on the number of sites that may be commissioned.<br/>- Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to.<br/><br/>Link to NHS England Regions:<br/>NHS England » Regional teams (https://www.england.nhs.uk/about/regional-area-teams/).<br/><br/>Inherited cancer predisposition syndromes are genetic conditions that increase the risk of developing one or more types of cancer. Scanning will be commissioned for three rare inherited cancer predisposition syndromes; Li-Fraumeni syndrome (LFS), constitutional mismatch repair deficiency syndrome (CMMRD) and rhabdoid tumour predisposition syndrome (RTPS).<br/><br/>Published clinical guidelines for these conditions recommend the use of regular whole-body MRI (WBMRI) with the aim of detecting cancers at an early stage. The provision of expanded capacity for WBMRI scanning aims to improve clinical care of individuals once an inherited cancer predisposition has been diagnosed.<br/><br/>Providers will:<br/>• Provide, interpret and report WB-MRI Scanning for the patient cohort described.<br/>• Provide, interpret, and report brain MRI Scanning (the first one with contrast when possible).<br/>• Establish effective pathways (including sharing results) with providers.<br/>• Be linked to regional genetic centres to allow continuity of care.<br/>• Facilitate communication with referrers including consultant clinical geneticists<br/>• Have capacity to plan and undertake WBMRI under general anaesthetic if re-quired.<br/>• Have information governance processes that permit sharing clinical and imaging data across organisations involved with providing a cancer surveillance service, and collection of clinical outcome and monitoring data.<br/>• Engage positively with associated patient support groups.<br/>• Ensure clear communication with Genetics Services and patients, to support patients to make decisions on where to access screening.<br/>• Work collaboratively with other organisations e.g. within imaging networks, to provide scanning and reporting capacity and expertise to meet the needs of their population including transition between paediatric and adult services.<br/>• Operate Quality Assessment processes according to CQC standards<br/>• Screening will be in addition to breast screening undertaken through the National VHRS Programme<br/>• Provide facilities will be in line with NHS guidance on Facilities for diagnostic imaging and interventional radiology.<br/>• Support continued educational initiatives for non-genetics healthcare professionals to improve expertise and understanding of cancer predisposition syndromes.<br/>• Liaise with partners across cancer alliances to support early diagnosis innovation opportunities<br/>• Ensure screening frequency will be in accordance with surveillance protocols.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 1 387 430.00  GBP

II.2) Description

II.2.2) Additional CPV code(s)

85100000

II.2.3) Place of performance

NUTS code:

UKC

UKD

UKE

UKF

UKG

UKH

UKI

UKJ

UKK

II.2.4) Description of the procurement

This notice sets out the intention to award a contract following a competitive procurement process for the provision of Specialised Adult whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes.<br/><br/>The Commissioner intends to award 10 individual contracts for this newly commissioned service, following this competitive process, to providers not previously contracted for this service.<br/><br/>Inherited cancer predisposition syndromes are genetic conditions that increase the risk of developing one or more types of cancer. Scanning will be commissioned for three rare inherited cancer predisposition syndromes; Li-Fraumeni syndrome (LFS), constitutional mismatch repair deficiency syndrome (CMMRD) and rhabdoid tumour predisposition syndrome (RTPS).<br/><br/>Published clinical guidelines for these conditions recommend the use of regular whole-body MRI (WBMRI) with the aim of detecting cancers at an early stage. The provision of expanded capacity for WBMRI scanning aims to improve clinical care of individuals once an inherited cancer predisposition has been diagnosed.<br/><br/>Providers will:<br/>• Provide, interpret and report WB-MRI Scanning for the patient cohort described.<br/>• Provide, interpret, and report brain MRI Scanning (the first one with contrast when possible).<br/>• Establish effective pathways (including sharing results) with providers.<br/>• Be linked to regional genetic centres to allow continuity of care.<br/>• Facilitate communication with referrers including consultant clinical geneticists<br/>• Have capacity to plan and undertake WBMRI under general anaesthetic if re-quired.<br/>• Have information governance processes that permit sharing clinical and imaging data across organisations involved with providing a cancer surveillance service, and collection of clinical outcome and monitoring data.<br/>• Engage positively with associated patient support groups.<br/>• Ensure clear communication with Genetics Services and patients, to support patients to make decisions on where to access screening.<br/>• Work collaboratively with other organisations e.g. within imaging networks, to provide scanning and reporting capacity and expertise to meet the needs of their population including transition between paediatric and adult services.<br/>• Operate Quality Assessment processes according to CQC standards<br/>• Screening will be in addition to breast screening undertaken through the National VHRS Programme<br/>• Provide facilities will be in line with NHS guidance on Facilities for diagnostic imaging and interventional radiology.<br/>• Support continued educational initiatives for non-genetics healthcare professionals to improve expertise and understanding of cancer predisposition syndromes.<br/>• Liaise with partners across cancer alliances to support early diagnosis innovation opportunities<br/>• Ensure screening frequency will be in accordance with surveillance protocols.<br/><br/>The approximate total lifetime value of all 10 contracts over the full 5 year contract term is circa £1,387,430.<br/><br/>The services are intended to commence on 1 July 2026, with an initial contract period to 30 June 2029, and an option to extend for up to a further two years, resulting in a maximum contract term of five years.<br/><br/>The intention to to award contracts to the following providers:<br/>Lot 1 - London<br/>Guy's and St Thomas' NHS Foundation Trust<br/>London North West University Healthcare NHS Trust<br/>The Royal Marsden NHS Foundation Trust<br/>Lot 2 – East of England<br/>Cambridge University Hospitals NHS Foundation Trust<br/>Lot 3 - South East<br/>University Hospitals Southampton NHS Foundation Trust<br/>Lot 4 – South West<br/>Royal Devon University Hospitals Trust<br/>Lot 5 – Midlands<br/>Nottingham University Hospitals NHS Trust Primary<br/>Lot 6 - North East and Yorkshire<br/>Leeds Teaching Hospitals NHS Trust<br/>Sheffield Teaching Hospitals NHS Foundation Trust<br/>Lot 7 - North West<br/>Manchester University NHS Foundation Trust (MFT)

II.2.5) Award criteria

Quality criterion: Key Criteria / Weighting: Pass/Fail

Price / Weighting:  0

II.2.11) Information about options

Options: Yes

Description of options:

Initial period of three (3) years with the Commissioner having the option to extend the Contract for up to a further two (2) years (maximum contract duration 5 years)

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

II.2.14) Additional information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of these contracts is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. <br/><br/>Representations by providers must be made to the relevant authority by Friday 29 May 2026. These contracts have not yet formally been awarded; this notice serves as an intention to award under the PSR. Representations should be sent to jessica.gaucher-thompson@nhs.net.<br/><br/>The award decision‑makers were NHS England’s National Commissioning Group (NCG). <br/><br/>The award decision was based on the outcome of a pass/fail evaluation against the published procurement requirements.<br/><br/>All key award criteria were assessed on a pass/fail basis and were considered of equal importance.<br/><br/>The providers selected for award successfully met all pass/fail requirements and were therefore assessed as compliant with the mandatory criteria.

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2025/S 000-068396

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/04/2026

V.2.2) Information about tenders

Number of tenders received: 14

Number of tenders received from SMEs: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Leeds Teaching Hospitals NHS Trust

00000N/A

Trust Headquarters, Beckett St, Harehills, Leeds

Leeds

LS9 7TF

UK

E-mail: leedsth-tr.btlw@nhs.net

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 154 640.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/04/2026

V.2.2) Information about tenders

Number of tenders received: 14

Number of tenders received from SMEs: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

London North West University Healthcare NHS Trust

LNWH Harrow Middlesex

London

HA1 3UJ

UK

NUTS: UKI

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 157 630.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/04/2026

V.2.2) Information about tenders

Number of tenders received: 14

Number of tenders received from SMEs: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Royal Devon University Hospitals Trust

Barrack Road, Exeter Devon

Devon

EX2 5DW

UK

Telephone: +44 7816525793

NUTS: UKK4

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 87 100.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/04/2026

V.2.2) Information about tenders

Number of tenders received: 14

Number of tenders received from SMEs: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

The Royal Marsden NHS Foundation Trust

00000N/A

Fulham Road, London

London

SW3 6JJ

UK

Telephone: +44 7402903350

NUTS: UKI

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 184 070.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/04/2026

V.2.2) Information about tenders

Number of tenders received: 14

Number of tenders received from SMEs: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Guy's and St Thomas' NHS Foundation Trust

00000N/A

Great Maze Pond. London

London

SE1 9RT

UK

NUTS: UKL12

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 222 215.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/04/2026

V.2.2) Information about tenders

Number of tenders received: 14

Number of tenders received from SMEs: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Cambridge University Hospitals NHS Foundation Trust

00000N/A

Hills Road, Cambridge

Cambridge

CB2 0QQ

UK

NUTS: UKH12

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 92 460.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/04/2026

V.2.2) Information about tenders

Number of tenders received: 14

Number of tenders received from SMEs: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Manchester University NHS Foundation Trust (MFT)

N\A

Trust Headquarters Cobbett House Oxford Road Manchester

Manchester

M13 9WL

UK

NUTS: UKD33

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 211 395.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/04/2026

V.2.2) Information about tenders

Number of tenders received: 14

Number of tenders received from SMEs: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

University Hospitals Southampton

Tremona Road Southampton

Southampton

SO16 6YD

UK

NUTS: UKJ32

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 102 085.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/04/2026

V.2.2) Information about tenders

Number of tenders received: 14

Number of tenders received from SMEs: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Sheffield Teaching Hospitals NHS Foundation Trust

00000N/A

8 Beech Hill Road

Sheffield

S10 2SB

UK

E-mail: kirsty.mallalieu@nhs.net

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 87 465.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/04/2026

V.2.2) Information about tenders

Number of tenders received: 14

Number of tenders received from SMEs: 3

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Nottingham University Hospitals NHS Trust Primary

00000N/A

City Hospital Campus, Hucknall Road,

Nottingham

NG5 1PB

UK

E-mail: invoices.trade@nuh.nhs.uk

NUTS: UKF14

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 88 370.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

NHS Arden and Greater East Midlands Commissioning Support Unit

Cardinal Square, 10 Nottingham Road

Derby

DE1 3QT

UK

Internet address(es)

URL: https://www.ardengemcsu.nhs.uk/

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

Representations by providers must be made to the relevant authority by Friday 29 May 2026. These contracts have not yet formally been awarded; this notice serves as an intention to award under the PSR. Representations should be sent to jessica.gaucher-thompson@nhs.net.

VI.5) Date of dispatch of this notice

18/05/2026

Coding

Commodity categories

ID Title Parent category
85100000 Health services Health and social work services

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
j.gaucher-thompson@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.